Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2′-Deoxycytidine with Tetrahydrouridine in Solid Tumors

Colin R. Young, Stephen Adler, Janet F. Eary, M. Liza Lindenberg, Paula M. Jacobs, Jerry Collins, Shivaani Kummar, Karen A. Kurdziel, Peter L. Choyke and Esther Mena
Journal of Nuclear Medicine April 2019, 60 (4) 492-496; DOI: https://doi.org/10.2967/jnumed.118.216994
Colin R. Young
1Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Adler
2Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., National Cancer Institute, Frederick, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet F. Eary
3Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Liza Lindenberg
4Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula M. Jacobs
3Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Collins
5Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivaani Kummar
6Stanford University School of Medicine, Palo Alto, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Kurdziel
4Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter L. Choyke
4Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Mena
4Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Maximum-intensity-projection PET imaging sequence after 18F-FdCyd injection in patient 2. Images demonstrate physiologic uptake in liver, gallbladder, kidneys, urinary bladder, small intestine, and mildly in bone marrow. There is modest tumor uptake in histologically confirmed spindle cell carcinoma at right parapharyngeal and masticator spaces, best seen on axial PET (A) and PET/CT (B). p.i. = after injection.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Mean biodistribution curves plotted for percentage injected dose per gram of organ mass vs. time. (A) Organs with higher uptake. (B) Organs with lower uptake. (C) Increasing urinary bladder activity. LLI = lower large intestine; SI = small intestine; ULI = upper large intestine; %ID/g = percentage injected dose per gram of organ mass.

Tables

  • Figures
    • View popup
    TABLE 1

    Dosimetry Estimates in mSv/MBq

    SiteAverageSD
    Adrenals1.83E−029.30E−03
    Brain8.17E−032.04E−03
    Breasts1.03E−021.01E−02
    Gallbladder wall4.05E−027.55E−03
    Lower large intestine wall2.52E−027.82E−03
    Small intestine2.13E−024.57E−03
    Stomach wall1.90E−023.27E−03
    Upper large intestine wall2.04E−026.43E−03
    Heart wall1.10E−021.82E−03
    Kidneys5.26E−022.23E−02
    Liver6.02E−022.74E−02
    Lungs1.82E−027.10E−03
    Muscle1.16E−021.35E−03
    Ovaries1.57E−022.22E−03
    Pancreas1.63E−024.27E−03
    Red marrow1.14E−022.19E−03
    Osteogenic cells1.71E−026.41E−03
    Skin8.65E−031.19E−03
    Spleen1.69E−025.55E−03
    Testes1.03E−022.38E−03
    Thymus1.12E−023.01E−03
    Thyroid8.23E−034.39E−03
    Urinary bladder wall7.96E−025.24E−02
    Uterus1.63E−024.99E−03
    Effective dose2.12E−024.15E−03
    • View popup
    TABLE 2

    Patient Demographics and TBR of Target Lesions on PET at 4 Time Points After Injection

    TBR
    Age (y)SexDiagnosis∼9 min∼32 min∼56 min∼2 h
    67MLeft parotid adenosquamous cell carcinoma1.41.51.51.6
    30MRight parapharyngeal spindle cell carcinoma1.91.71.71.6
    65FNon–small cell lung cancer1.41.41.51.7
    51FNon–small cell lung cancer2.42.11.62.0
    63MHepatocellular carcinomaNANANANA
    • NA = not applicable: patient 5’s tumor was within liver, and activity within tumor was not clearly discernable from remainder of liver parenchyma. Therefore, TBRs were not included for this subject because of concern about reporting misleading values in setting of high background/surrounding liver uptake.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (4)
Journal of Nuclear Medicine
Vol. 60, Issue 4
April 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2′-Deoxycytidine with Tetrahydrouridine in Solid Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2′-Deoxycytidine with Tetrahydrouridine in Solid Tumors
Colin R. Young, Stephen Adler, Janet F. Eary, M. Liza Lindenberg, Paula M. Jacobs, Jerry Collins, Shivaani Kummar, Karen A. Kurdziel, Peter L. Choyke, Esther Mena
Journal of Nuclear Medicine Apr 2019, 60 (4) 492-496; DOI: 10.2967/jnumed.118.216994

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2′-Deoxycytidine with Tetrahydrouridine in Solid Tumors
Colin R. Young, Stephen Adler, Janet F. Eary, M. Liza Lindenberg, Paula M. Jacobs, Jerry Collins, Shivaani Kummar, Karen A. Kurdziel, Peter L. Choyke, Esther Mena
Journal of Nuclear Medicine Apr 2019, 60 (4) 492-496; DOI: 10.2967/jnumed.118.216994
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer
  • Google Scholar

More in this TOC Section

Oncology

  • The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumors
  • Utility of bone scans in patients with RCC
  • Disseminated xanthogranulomatous oophoritis mimicking malignancy on 18F-fluorodeoxyglucose positron emission tomography/computed tomography
Show more Oncology

Translational

  • [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
  • Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET
  • Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
Show more Translational

Similar Articles

Keywords

  • 18F-FdCyd
  • Tetrahydrouridine
  • PET imaging
  • cancer
  • Molecular imaging
SNMMI

© 2025 SNMMI

Powered by HighWire